DWI定量ADC检测TACE后肝癌残留或复发的Meta分析
本Meta分析纳入16项研究,共818例患者、971个病灶,评估DWI联合定量ADC检测TACE后肝细胞癌残留或复发的诊断效能。结果显示合并敏感度0.78,特异度0.83,SROC曲线下面积0.88,诊断比值比13.89。该技术总体诊断准确性良好,可作为常规影像的补充手段,而非独立替代。
要点
- DWI联合ADC对TACE后残留/复发肝癌特异度较好,适合用于排除性诊断。
- 敏感度中等偏低,阴性结果不能完全除外残留或复发。
- 该技术应作为常规增强影像的辅助手段,不宜单独使用。
核心结论
- DWI联合定量ADC检测TACE后肝癌残留或复发总体诊断准确性良好,SROC曲线下面积为0.88。
- 该技术特异度中等偏高(0.83),敏感度相对一般(0.78),目前应作为常规影像的补充手段而非独立替代。
研究设计与样本
- 研究类型为诊断性Meta分析,检索PubMed、Embase、Web of Science及Cochrane Library截至2025年9月的文献。
- 共纳入16项研究,包含818例患者和971个病灶,采用双变量随机效应模型合并诊断效能指标。
- 研究方案在INPLASY平台注册,注册号为INPLASY2025100047。
诊断标准与关键数值
- 合并敏感度为0.78(95% CI:0.70-0.85),合并特异度为0.83(95% CI:0.77-0.87)。
- 合并阳性似然比为4.53(95% CI:3.28-6.26),合并阴性似然比为0.26(95% CI:0.18-0.37)。
- 合并诊断比值比为13.89(95% CI:8.46-22.82),SROC曲线下面积为0.88(95% CI:0.85-0.90)。
- 亚组分析显示前瞻性研究的诊断准确性(AUC)显著高于回顾性研究。
临床应用与阅片要点
- DWI定量ADC对TACE后残留或复发病灶有良好鉴别能力,可辅助常规增强序列判断疗效。
- 该技术特异度较高,阳性结果提示残留或复发的可信度较好,但敏感度有限,阴性结果需结合增强表现综合判断。
局限性
- 纳入研究之间存在异质性,采用随机效应模型进行合并分析。
- 前瞻性亚组与回顾性亚组的诊断准确性存在显著差异,回顾性研究可能导致效能偏倚。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
BACKGROUND: Accurate detection of residual or recurrent hepatocellular carcinoma (HCC) after transarterial chemoembolization (TACE) is critical for guiding subsequent management but remains challenging with conventional imaging. Diffusion-weighted imaging (DWI) with quantitative apparent diffusion coefficient (ADC) has emerged as a functional MRI technique that may improve diagnostic accuracy in this setting, though evidence remains heterogeneous.
OBJECTIVE: To assess the diagnostic performance of DWI combined with quantitative ADC for identifying residual or recurrent HCC following TACE.
METHODS: A literature search of PubMed, Embase, Web of Science, and the Cochrane Library was conducted for studies published up to September 2025. Pooled estimates for sensitivity, specificity, positive likelihood ratio (PLR), negative likelihood ratio (NLR), diagnostic odds ratio (DOR), and summary receiver operating characteristic (SROC) curve metrics were derived using a bivariate random-effects model to account for anticipated heterogeneity.
RESULTS: The meta-analysis included 16 studies, encompassing 818 patients and 971 lesions. The pooled sensitivity was 0.78 (95% CI: 0.70-0.85), and the pooled specificity was 0.83 (95% CI: 0.77-0.87). The pooled PLR was 4.53 (95% CI: 3.28-6.26), the NLR was 0.26 (95% CI: 0.18-0.37), and the DOR was 13.89 (95% CI: 8.46-22.82). The area under the SROC curve was 0.88 (95% CI: 0.85-0.90). Subgroup analysis indicated that the diagnostic accuracy (AUC) was significantly higher in prospective studies compared to retrospective studies.
CONCLUSIONS: DWI with quantitative ADC demonstrates good overall diagnostic accuracy for detecting residual or recurrent HCC after TACE. The technique offers moderate-to-high specificity but more modest sensitivity, and should currently be considered a complementary adjunct to conventional imaging rather than a standalone replacement.
REGISTRATION: The review protocol was registered on INPLASY platform (Registration number: INPLASY2025100047).
引用
- Wang. Diagnostic performance of diffusion-weighted imaging with quantitative apparent diffusion coefficient for detecting residual or recurrent hepatocellular carcinoma after TACE: a meta-analysis. Abdom Radiol (NY). 2026. PMID: 42789050. doi:10.1007/s00261-026-05753-1
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。